financetom
Business
financetom
/
Business
/
Goldman explores options for platform clients use to launch ETFs, source says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman explores options for platform clients use to launch ETFs, source says
Dec 6, 2024 11:20 AM

(Reuters) - Goldman Sachs ( GS ) is exploring options, including a potential sale, for its ETF Accelerator platform designed to help the bank's institutional clients launch their own exchange-traded funds, a source familiar with the matter told Reuters on Friday.

This platform is separate from the ETF business of Goldman Sachs' ( GS ) asset management arm, the source said, who did not want to be identified because the plans are not public.

"We are assessing what the best long-term option is for the ETF Accelerator platform for Goldman Sachs ( GS ) and our clients," said Nick Carcaterra, a spokesperson for the bank, in an emailed statement.

"No decision has been made and there are no imminent plans for a change. If we have an update to share, we will do so," he added.

The news was first reported by Bloomberg News.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing
Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing
Dec 16, 2024
04:02 AM EST, 12/16/2024 (MT Newswires) -- Suma Krishnan, 10% Owner, Director, President, Research & Development, on December 13, 2024, sold 50,000 shares in Krystal Biotech ( KRYS ) for $8,240,023. Following the Form 4 filing with the SEC, Krishnan has control over a total of 3,153,144 shares of the company, with 1,475,882 shares held directly and 1,677,262 controlled indirectly....
Globalstar Insider Sold Shares Worth $7,752,850, According to a Recent SEC Filing
Globalstar Insider Sold Shares Worth $7,752,850, According to a Recent SEC Filing
Dec 16, 2024
03:59 AM EST, 12/16/2024 (MT Newswires) -- Timothy Evan Taylor, Director, Vice President, Finance & Operations, on December 11, 2024, sold 3,500,000 shares in Globalstar ( GSAT ) for $7,752,850. Following the Form 4 filing with the SEC, Taylor has control over a total of 9,837,893 shares of the company, with 3,454,244 shares held directly and 6,383,649 controlled indirectly. SEC...
Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing
Krystal Biotech Insider Sold Shares Worth $8,240,023, According to a Recent SEC Filing
Dec 16, 2024
04:00 AM EST, 12/16/2024 (MT Newswires) -- Krish S Krishnan, 10% Owner, Director, President and Chief Executive Officer, on December 13, 2024, sold 50,000 shares in Krystal Biotech ( KRYS ) for $8,240,023. Following the Form 4 filing with the SEC, Krishnan has control over a total of 3,153,144 shares of the company, with 1,537,262 shares held directly and 1,615,882...
Akoustis Technologies Files for Chapter 11 Bankruptcy
Akoustis Technologies Files for Chapter 11 Bankruptcy
Dec 16, 2024
03:56 AM EST, 12/16/2024 (MT Newswires) -- Akoustis Technologies ( AKTS ) said Monday it filed for a Chapter 11 relief in a bankruptcy court for the District of Delaware. The move follows a recent court ruling ordering the company to pay $59 million in damages and fees in a patent dispute with Qorvo ( QRVO ) , the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved